91
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Irritable bowel syndrome in general practice: an overview

, , , &
Pages 17-22 | Published online: 08 Jul 2009

References

  • Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45 Suppl 2:II1–II5.
  • Manning AP, Thompson WD, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. BtMed J. 1978;2:653–4.
  • Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1–7.
  • Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989;2:92–5.
  • Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45:43ii–7.
  • Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76–83.
  • Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992;304:87–90.
  • Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–80.
  • Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ, III. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2816–24.
  • Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155–61.
  • Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225–35.
  • Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology. 1980;79:283–8.
  • Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol 1997;9:689–92.
  • Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46:78–82.
  • Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17: 643–50.
  • Lamberts H. In het huis van de huisarts. Verslag van het Transitieproject. Lelystad: Meditekst; 1991.
  • van der Velden J, de Bakker D, Claessens AAMC, Schellevis FG. Nationale studie naar ziekten en verrichtingen in de huisarts- praktijk. Basisrapport morbiditeit in de huisartspraktijk. Utrecht: NIVEL; 1991.
  • Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol Suppl 1993;200:33–41.
  • Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992;116:1009–16.
  • Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut. 1999;45 Suppl 2:II25–II30.
  • Ruigomez A, Wallander MA, Johansson S, Garcia-Rodriguez LA. One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13:1097–102.
  • Bertram S, Kurland M, Lydick E, Locke GR, III, Yawn BP. The patient’s perspective of irritable bowel syndrome. J Fam Pract 2001;50:521–5.
  • van der Horst HE, van Dulmen AM, Schellevis FG, van Eijk JT, Fennis JF, Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997;41:669–74.
  • Whitehead WE. Psychosocial aspects of functional gastrointestinal disorders. Gastroenterol Clin North Am 1996;25:21–34.
  • Mayer EA, Thompson WG, Dent J. Irritable bowel syndrome: diagnosis, subgrouping, management, and clinical trial design [Introduction]. Am J Med 1999;107:1S–4S.
  • Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988; 95:701–8.
  • Whitehead WE, Bosmajian L, Zonderman AB, Costa PT, Jr, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988;95:709–14.
  • Drossman DA. Illness behaviour in the irritable bowel syndrome. Gastroenterol Int 1991;4:77–81.
  • Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation. Mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am 1996;25:247–58.
  • Bleijenberg G, Fennis JF. Anamnestic and psychological features in diagnosis and prognosis of functional abdominal complaints: a prospective study. Gut 1989;30:1076–81.
  • Drossman DA. Irritable bowel syndrome. Gastroenterologist 1994;2:315–26.
  • Harvey I, Nelson SJ, Lyons RA, Unwin C, Monaghan S, Peters TJ. A randomized controlled trial and economic evaluation of counselling in primary care. Br J Gen Pract 1998;48:1043–8.
  • Simren M, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545–52.
  • Barnes J. When to investigate and treat IBS symptoms. Practitioner. 1996;240:184–7.
  • Thompson WG. Irritable bowel syndrome. Strategy for the family physician. Can Fam Physician 1994;40: 307–10313–6.
  • Harris MS. Irritable bowel syndrome: a cost effective approach for primary care physicians. Postgrad Med 1997;101:215–5.
  • Bleijenberg G, Fennis JF. Prospective study of the course of functional abdominal symptoms. Ned Tijdschr Geneeskd 1987; 131:2142–6.
  • Coremans G, Dapoigny M, Müller-Lissner S, Pace F, Smout A, Stockbrügger RW, et al. Diagnostic procedures in irritable bowel syndrome. Digestion 1995;56:76–84.
  • Paterson WG, Thompson WG, Vanner SJ, Faloon TR, Rosser WW, Birtwhistle RW, et al. Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. Can Med Assoc J 1999;161: 154–60.
  • Thompson WG, Hungin AP, Neri M, Holtmann G, Sofos S, Delvaux M, et al. The management of irritable bowel syndrome: a European, primary and secondary care collaboration. Eur J Gastroenterol Hepatol 2001;13:933–9.
  • Fass R, Longstreth GF, Pimentel M, Fullerton S, Russak SM, Chiou CF, et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med 2001;161:2081–8.
  • van der Horst HE, Meijer JS, Muris JWM, Sprij B, Visser FMPB, Romeijnders ACM, et al. NHG-Standaard Prikkelbare Darm Syndroom (irritable bowel syndrome). Huisarts Wet 2001; 44: 58–62.
  • Bijkerk CJ, de Wit NJ, Stalman WAB, Knotterus JA, Hoes AW, Muris JWM. Irritable bowel syndrome in primary care; the patient’s and doctor’s view on symptoms, aetiology, and management. Can J Gastroenterol 2003:363–8.
  • Fennis JF, Bleijenberg G, Hermans van Wordragen R. Psychologic factors in diagnosis, prognosis, and treatment of functional abdominal complaints. Scand J Gastroenterol 1990;Suppl 178: 13–6.
  • Pace F, Coremans G, Dapoigny M, Muller Lissner SA, Smout A, Stockbruegger RW, et al. Therapy of irritable bowel syndrome: an overview. Digestion 1995;56:433–42.
  • Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994;8:499–510.
  • Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136–47.
  • Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355–61.
  • Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001;19:643–53.
  • Whitehead WE, Burnett CK, Cook EW, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996;41: 2248–53.
  • Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;110:999–1007.
  • Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654–60.
  • Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907–13.
  • Hahn BA, Kirchdoerffer LJ, Fullerton S, Mayer EA. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality oflife. Aliment Pharmacol Ther 1997;11:553–9.
  • Akehurst RL, Brazier JE, Mathers N, O’Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002;20:455–62.
  • Donker GA, Foets M, Spreeuwenberg P. Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract 1999;49:787–92.
  • Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study [see comments]. Gut 1997;41:394–8.
  • Osterberg E, Blomquist L, Krakau I, Weinryb RM, Asberg M, Hultcrantz R. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000;35:264–8.
  • Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314–8.
  • Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992;33:825–30.
  • Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001;96:1340–9.
  • Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409–15.
  • Shih YC, Barghout VE, Sandler RS, Jhingran P, Sasane M, Cook S, et al. Resource utilization associated with irritable bowel syndrome in the United States 1987–1997. Dig Dis Sci 2002;47: 1705–15.
  • Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med 1993;329:1940–5.
  • Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome [comment]. Gastroenterology 1995;109:1736–41.
  • Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500–11.
  • Fullerton S. Functional digestive disorders (FDD) in the year 2000: economic impact. Eur J Surgery 1998;164 Suppl 582:62–4.
  • Wells NEJ, Hahn BA, Whorwell PJ. Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 1019–30.
  • Levy RL, Von Korff M, Whitehead WE, Stang P, Saunders K, Jhingran P, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122–9.
  • Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80.
  • Hahn BA, Yan SK, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999;60:77–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.